Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision tag has been updated from v3.6.6 to v3.7.0. This indicates a new build/patch of the ClinicalTrials.gov page, without affecting the study content or presentation.
    Difference
    0.0%
    Check dated 2026-09-15T20:48:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, representing a new version of the page. This update likely reflects minor edits or metadata adjustments rather than a major content change.
    Difference
    0.0%
    Check dated 2026-09-01T18:57:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new NIH grant/contract identifier was added to the study's list of other identifiers, indicating NIH funding attribution for the RUBY trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:57:19.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The author list in the Publications citation for the Dostarlimab NEJM paper has been deleted, altering the attribution shown for that study reference.
    Difference
    0.1%
    Check dated 2026-08-18T19:36:58.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A new NEJM publication citation for Dostarlimab in primary advanced or recurrent endometrial cancer was added, listing authors and article details. The page revision history was updated from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-11T18:24:24.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a recent internal update to the site's revision. No visible content or user-facing changes are indicated.
    Difference
    0.0%
    Check dated 2026-07-21T12:38:58.000Z thumbnail image

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.